NEW YORK (Reuters Health) - On average, men's levels of prostate-specific antigen (PSA) decrease as their body mass index (BMI) rises, a new study shows. PSA is a marker for prostate cancer risk when ...
Prostate-specific antigen (PSA) is a protein made by the prostate gland. A high PSA level could be a sign of an enlarged prostate, inflammation called prostatitis, or prostate cancer. The PSA test ...
Use of statins and non-steroidal anti-inflammatory drugs may interfere with prostate cancer screening. Two of the most common classes of medication — statins and nonsteroidal anti-inflammatory drugs ...
November 18, 2008 (Washington, DC) — The use of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) is significantly associated with lower levels of prostate-specific antigen (PSA).
Image of PSA screening. Black men have a higher risk of prostate cancer at younger ages and lower PSA values than White men, a new study suggests. Black men have a higher risk of prostate cancer at ...
Black men in the United States are more likely to develop prostate cancer than white men, and after diagnosis, they're more likely to have advanced disease and to die than white men with the disease.